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One hundred years ago Paul Ehrlich and Ilya 
Mechnikov won the 1908 Nobel Prize in physiology and 
medicine for their great contribution to our understanding of 
the immune system. Their pioneering work has led us into a 
new world: the critical role of immunity in human diseases. 
Today we are following their steps. 
 ii
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Immunity is the body's capability to repel foreign substances and cells in order to protect an 
organism from disease. Immunity has been divided into innate immunity (also named natural or 
native immunity) and adaptive immunity (also named specific immunity). Innate immunity is the 
first line of defence against invading micro organisms and provides clues to adaptive immunity 
on building memory for subsequent infections. Adaptive immunity is a secondary process 
mediated by T cells and B cells. Their collective and coordinated response to the introduction of 
foreign substances is called immune response. Response to intracellular pathogens is known as 
cellular immune response (cell mediated immunity) and involves sensitized T cells that attack 
and lyse target cells. Response to circulating pathogens (extra-cellular) is mediated by humoral 
response (humoral immunity), which involves B cell maturation into plasma cells and production 
of pathogen-binding antibodies [1]. Appropriated and balanced magnitudes of both immunities 
determine the direction of an immune response and eventually patients’ outcomes.  
 
1.2  T helper cells 
T helper (Th) subsets originate from a common naïve precursor (Th0). During the immune 
response Th0 cells encounter antigens presented by antigen presenting cells (APC) and 
differentiate into their subsets Th1 or Th2 [2, 3]. Th1-type cytokines such as tumour necrosis 
factor-alpha (TNF-α) or interferon-gamma (IFN-γ) are known to mediate inflammation. Th2-
type cytokines such as interleukin (IL) -4, IL-5 and IL-10 mediate anti-inflammation. There is 
some evidence that rather relative proportions of Th1- and Th2-responses (Th1-Th2-ratio) and 
not absolute cytokine activity are the major determinants of the immune response. 
Recently two new Th subsets, Treg (T regulatory cells) and Th17 have been described. Their role 
in immunity is gradually being discovered.  
Activation, differentiation and development of Th cell subsets in immune responses are 
modulated by many factors including quantity, duration and strength of pathogen stress, 
cytokines secreted by APCs as well as T cell receptor (TCR) signalling. Although these factors 
show a rather complex interaction within the immune response, more and more evidence 
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indicates that each Th subset is controlled by its own specific transcription factor [4]. 
Modern molecular biology revealed that transcription factors, usually located in the cytoplasm, 
can move to cell nuclei where they bind to specific recognition motifs leading to an up-
regulation of gene transcription succeeded by formation of messenger RNA (mRNA) and 
adjacent protein synthesis [5]. Some transcription factors are cell specific, others ubiquitous.  
Recent studies showed that Th cell subsets interact with specific transcription factors including 
T-bet, GATA3, Foxp3 and ROR-γt. Universal, unspecific transcription factors like SOCS1 and 
SOCS3 have also been described. In vitro experiments proved that such transcription factors are 
modulated by environmental signals and influence the differentiation of Th subsets thus 
impacting immune response [6]. However, so far little information is available on expression 
patterns and interaction of transcription factors in perioperative settings. Understanding function 
and regulation of transcription factors in human immune response to surgery may provide novel 
therapeutic strategies in perioperative medicine. 
 
1.2.1 T-bet - a Th1 specific transcription factor 
IFN-γ is the key Th1-proinflammatory cytokine in cellular immunity. Interestingly Lighvani et al. 
assessed that secretion of IFN-γ was always accompanied with an expression of transcription 
factor T-bet. T-bet enhanced production of IFN-γ and IL12 forming a potential positive feedback 
loop of Th1 development [7, 8]. This finding elicits the key role of T-bet in Th1 differentiation 
and proliferation. 
T-bet (T-box expressed in T cells) is a 530-amino acid protein with a 189-amino acid T box 
DNA-binding domain, which is rapidly and selectively induced in Th1 cells but not in Th2 cells. 
T-bet, also known as Tbx21 [9], belongs to the T-box family of transcription factors and is the 
only known T-box gene specifically expressed in the lymphoid system. Its critical role in the 
development of Th1 was confirmed in T-bet-/- mice. The study by Szabo showed that in the 
absence of T-bet, CD4+ T cells failed to differentiate into Th1 lineage and default to Th2 fate 
while retroviral gene transduction of T-bet into polarized Th2 and Tc2 primary T cells redirected 
them into Th1 and Tc1 cells [10]. 
Animal models described the role of T-bet in inflammation. Mice lacking T-bet failed to mount 
Th1 response in vivo following either protein antigen immunization or Leishmania infection but 
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reacted with an increase in Th2-type cytokines [11]. T-bet deficient mice were found more 
susceptible to tuberculosis infection with increased systemic bacterial burden, diminished IFN-γ 
production in the lung [12]. 
Although perioperative immune reaction in humans has been described in several studies the role 
of T-bet in a bed side setting remains unexplored.  
 
1.2.2 GATA3 - a Th2 specific transcription factor 
IL-4 has always been thought to play a central role in polarizing naïve Th cells towards Th2 and 
in powerfully suppressing the appearance of IFN-γ-producing Th1 cells. Recent studies 
surprisingly suggest that transcription factor GATA3 and not IL-4 is responsible for this shift 
towards Th2. Originally this factor was cloned as a transcription factor that binds to enhancers of 
TCR-α and δ genes [13, 14]. Three years later, Zheng W. et al. where the first to find that GATA3 
is selectively expressed in Th2 cells and that in transgenic mice elevated GATA3 in CD4+ T 
lymphocyte caused Th2 cytokine gene expression in developing Th1 cells [15]. Later this finding 
was confirmed by other groups [16, 17]. After that, more positive evidence emerged: antisense-
GATA3 could repress Th2-cell responses in vivo, which further implied the requirement of 
GATA3 for Th2-cell development [18]. Even more important is that an expression of GATA3 
using retroviral constructs can up-regulate endogenous GATA3, suggesting that this transcription 
factor auto-regulates creating a positive feedback loop that stabilizes the Th2 polarization [19, 
20]. Besides the effect on Th2 commitment, GATA3 strongly inhibits production of IFN-γ which 
consequently lowers differentiation of Th1 and leads to a polarization of Th2 [16, 21]. 
Several clinical studies suggest that a shift towards Th2 in the Th1/Th2-ratio after surgery or 
trauma significantly worsens patients outcomes [22], [23].  
Nowadays there is no hard evidence that GATA3 leads to a Th2-shift in perioperative settings 
and the mechanisms of perioperative immune answers in humans remain unclear. According to 
the importance of the Th2-response following surgery, further studies are needed to clarify 
underlying molecular mechanisms of this Th2-answer and the exact role of transcription factor 
GATA3. 
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1.2.3 FOXP3 - a Treg specific transcription factor 
Treg (Regulatory T cell) is a subset of T lymphocytes which is characterized by a CD4 and CD25 
double positive surface marker. It was first identified by Sakaguchi and his colleagues, who 
found that CD4+CD25+ cells can prevent T cell-mediated organ-specific autoimmune diseases 
and account for approximately 7-10% of peripheral CD4+ lymphocytes and less than 1% of 
CD8+ lymphocytes in adult mice and humans [24]. Before that, Treg was usually called 
suppressor cell because of its counter-regulation or suppression of immune responses mediated 
by Th1 and Th2 [25]. Besides its autoimmune suppression, Treg was found to have the ability of 
limiting collateral tissue damage caused by protective immune responses against pathogens and 
maintaining immune homeostasis. Hori et al. found out that the transfer of Treg into 
Pneumocystis carini-infected recombination-activating gene-2-deficient mice did not induce 
lethal pneumonia and prevented development of this disease while all control mice died within 
13 days [26]. Treg also seems to modulate inflammation within keratitis lesions thus limiting 
their severity, perhaps by secreting IL-10 [27].  
Recently FOXP3 (fork head box P3, an X chromosome–encoded fork head transcription factor 
family member,) has been identified as the specific transcription factor of Treg. Its expression is 
specifically restricted to the Treg subset [27-29]. The indispensable role of FOXP3 in the 
development of Treg cells was illustrated by recent studies: FOXP3 deficient mice develop a 
rapid and fatal lymphoproliferative autoimmune syndrome at 3–4 weeks of age [30, 31] and 
FOXP3 deficient mice fail to generate a Treg population. Mutations in the human orthologue of 
FOXP3 result in a fatal autoimmune syndrome known as IPEX (Immune dysregulation, 
polyendocrinopathy, enteropathy and X-linked inheritance) [32, 33]. Fontenot et al. verified that 
CD4+ CD25+ regulatory T cells could prevent this lethal autoimmune syndrome in FOXP3 
deficient mice and expanded preferentially when it was transferred into neonatal FOXP3 
deficient mice. In addition, continued expression of FOXP3 was demonstrated to be crucial for 
the maintenance of Treg differentiation [34]. Although the relation between Treg and FOXP3 has 
been confirmed in many in vitro and in vivo experiments the role of FOXP3 in clinical and 
particularly perioperative settings remains unclear. 
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1.2.4 ROR-γ - a Th17 specific transcription factor 
Th17, named after its specific pro-inflammatory cytokine IL17, has been recently identified as a 
new, distinct Th lineage mediating tissue inflammation. It was discovered by Infante-Duarte and 
colleagues [35], who found out that some Th cells in a murine model but also in humans can 
secrete IL17. IL17 succeeds microbial stimuli and belongs neither to Th1 nor to Th2 cytokines. 
Specific analysis showed that Th17 development lacks the expression of all key signalling 
components of Th1 and Th2 differentiation, supporting the theory of Th17 as product of a 
separate effector lineage [36, 37]. Consistent with these findings, Oppmann et al found a new 
Th17 cytokine - IL23 [38]. IL23 is described as being critical for Th17-mediated immunity and 
host protection by amplifying and stabilizing Th17 answer through a positive feedback loop [39, 
40] 
Within tissues, Th17 effector cells stimulate production of a variety of inflammatory chemokines, 
cytokines, and other pro-inflammatory mediators and promote or enhance inflammation [41, 42]. 
Neutralization of IL-17, but not genetic deletion of Th1 cells, was proved to resolve tissue 
pathology in autoimmune models [43, 44]. Furthermore, experimental models suggest that Th17 
cells may be of importance in neutrophilic inflammation of acute airway inflammation [45-49].  
On the other hand, Th17 appears to interact with Treg. Patients with acute coronary syndrome 
show significant increase in peripheral Th17 and its relative cytokines (IL-17, IL-6 and IL-23), 
as well as a decrease in Treg and its related cytokines (IL-10 and TGF-β1) [50]. This imbalance 
of Th17 and Treg has also been observed in the treatment of galectin-9 on collagen-induced 
arthritis (CIA) in a mouse model [51]. All of these findings imply that Th17 and Treg play an 
important role in modulating T lymphocytes in inflammation. 
Similar as Th1, Th2 and Treg Th17 has its own lineage-specific transcription factor: Retinoic 
acid receptor-related orphan receptor gamma (ROR-γ). ROR-γ was recently identified by Ivaylo 
et al. [52]. ROR-γ is normally expressed in developing thymocytes (CD4+, CD8+) as well as in 
lymphoid tissue inducer (LTi) cells and LTi-like cells [53]. In ROR-γ deficient mice, Th17 
number and IL17 secretion were markedly reduced, though not completely eliminated. In 
addition, a deficiency in ROR-γ globally impaired Th17 generation and completely protected 
mice against experimental autoimmune encephalomyelitis [54]. Conversely, an enforced 
expression of ROR-γ in naive CD4 T cells resulted in IL-17 production by approximately one-
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half of cells that expressed ROR-γ. This result was in contrast to that of T-bet transduced cells, 
which did not show significant IL-17 expression [52]. 
 
1.2.5 SOCS1 and SOCS3 - Two negative modulators of Th cell development 
It is well accepted that Th cell development has to be modulated negatively, too. Otherwise, the 
number of Th cells and secretion of cytokines will be out of control, once immune response is 
initiated. Recently, SOCS (Suppressor of cytokine signalling) is thought to play this important 
role. SOCS comprises a family of intracellular proteins, including eight members, CIS (cytokine-
inducible SH2 protein), SOCS1, SOCS2, SOCS3, SOCS4, SOCS5, SOCS6 and SOCS7. Each of 
them has a common central SH2 domain, a N-terminal domain of variable length and sequence 
and a C-terminal 40-amino-acid module called the SOCS box [55-58]. Interestingly, a 
comparison of the primary amino acid sequence of SOCS subfamily members shows that pairs 
of SOCS proteins, SOCS1 and SOCS3, CIS and SOCS2, SOCS4 and SOCS5, SOCS6 and 
SOCS7, are more similar to each other than to other SOCS proteins [59]. SOCS proteins are 
normally present in cells at low or undetectable levels, but are rapidly induced by a board 
spectrum of cytokines, both in vitro and in vivo [60, 61].  
Negative modulation mechanisms of SOCS1 and SOCS3 have been revealed recently (Fig. 1). 
Briefly, cytokines bind to their receptors on the T cell surface, leading to a dimerization of 
receptors and activation of so called receptor-associated Janus Kinase (JAK). Activated JAK 
proteins phosphorylate receptors creating binding sites for STATs (signal transducers and 
activators of transcription) which are as well phosphorylated by JAK. Once phosphorylated, 
STAT proteins can dimerize and upon transport into nuclei induce transcription of many 
cytokine-regulated genes. Meanwhile, activated STATs also induce transcription of SOCSs, 
which in turn inhibit the JAK-STATs signalling pathway that initially led to their production, 
forming a potent negative feedback loop [62-64]. Because the JAK-STATs pathway is the crucial 
component to both Th1 and Th2 signalling, like JAK-STAT6 to Th1, JAK-STAT3 toTh2, an 
activation of STATs will induce SOCS’ negative signalling modulation. 















Figure 1: The role of SOCS family in the differentiation of Th cells 
Green arrow indicates up-regulation, while the red arrow indicates inhibition.  
STAT: Signal Transducers and Activators of Transcription; SOCS: Suppressor of cytokine signalling. 
 
SOCS1 was cloned in 1997 by three independent groups and proved playing a critical role in 
immune response by modulating T cells activation, development and differentiation. SOCS1 
deficient mice are normal at birth, later they show stunted growth and die with 3 weeks of age 
with a syndrome characterized by severe lymphopenia, aberrant peripheral T cells activation, 
fatty degeneration and necrosis of liver, as well as macrophage infiltration of major organs [65, 
66]. Mice lacking of SOCS1 skew thymocyte development toward the CD8+ single-positive 
lineage [67, 68]. SOCS1 deficient CD4+ cells produced relative high amounts of IFN-γ and IL4 
than do wide-type CD4+ T cells in response to anti-CD3 stimulation [69] indicated that SOCS1 
regulated both Th1 and Th2 polarizations. In addition, evidence from T-cell receptor-transgenic T 
cells suggested SOCS1 was highly expressed in Th1 cells, which implied that SOCS1 might 
mainly negatively regulate Th1 differentiation, toward a Th2 polarization and humoral immunity 
[70]. SOCS1 has also an important regulatory function in APC, such as macrophages and 
dendritic cells, which play key roles for inflammation, septic shock and innate immunity [71-73].  
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SOCS3 has a similar structure to SOCS1, but the immune functions are different. SOCS3 
deficient mice exhibited embryonic lethality with death occurring between days 11 and 13 of 
gestation because of the defect of placental development. Leukaemia Inhibitory Factor Receptor 
(LIFR) deficiency rescued this defect and embryonic lethality, implying SOCS3 as an essential 
regulator of LIFR signalling in trophoblast giant cell differentiation [74, 75]. Like SOCS1, 
SOCS3 is also involved in T cell differentiation but selectively expresses in Th2 cells [70]. Seki 
et al demonstrated that SOCS3 transgenic mice showed increased Th2 responses and multiple 
pathological features characteristic of asthma in an airway hypersensitivity model system. In 
contrast, SOCS3 deficient mice had decreased Th2 development. These data indicate that SOCS3 
has an important role in regulating the onset and maintenance of Th2 polarization [76]. SOCS3 
had been shown to regulate the TLR (toll-like receptor) signalling, impacting the innate immune 
System. In Yasukawa’s study, SOCS3 was strongly induced by both IL6 and IL10 in the presence 
of lipopolysaccharide (LPS), but selectively inhibited IL6 signalling by binding the IL6 receptor 
gp130 but not the IL10 receptor. Mice specifically lacking SOCS3 in macrophages and 
neutrophils are resistant to LPS induced septic shock [77]. Recently SOCS3 was found to be an 
essential negative regulator of IL-23 signalling, inhibition of which constrains the generation of 
Th17 differentiation [78]. 
 
1.3 Lung surgery and Anaesthesia 
 
1.3.1 Lung surgery 
Lung surgery includes a variety of procedures to diagnose and treat pulmonary diseases. 
Pneumonectomy, lobectomy, segmentectomy and wedge resection are standard procedures in 
lung surgery and are mostly performed in patients diagnosed with bronchial carcinoma or 
pulmonary metastases. Lung surgery is known to be associated with high tissue damage and high 
postoperative pain levels, which both negatively influence patient outcomes. 
According to Harpole et al. thirty-day mortality of patients undergoing lobectomy and 
pneumonectomy is 4% and 11.5% respectively; overall thirty-day morbidity amounts to 24.1% 
and the most frequently occurring complication is pneumonia (11.7% for lobectomy and 9.7% 
for pneumonectomy) [79].  
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Despite significant improvements in the fields of thoracic surgery and intensive care medicine, 
in-hospital morbidity rates assessed in more recent studies still range between 1.95% and 4.1% 
(Tab.1). These findings suggest that further improvements are needed. Specific interventions 
aimed at reducing perioperative morbidity and mortality could save thousands of lives each year 
worldwide. 
Table 1. Morbidity and mortality in thoracic surgery 
Year No. patients No. of deaths Setting 
1999-2001 [80] 4028 103 (2.6%) 36 departments in the UK 
2001-2003 [81] 3426 66 (1.9%) 27 departments in 14 countries 
2004-2006 [82] 695 20 (2.3%) 3 departments in 3 countries 
 
1.3.2 Immune response in major surgery 
It is well known that surgical insult can induce a widespread alteration of immune functions such 
as natural killer (NK) cell activity [83], lymphocyte proliferation [84] and cytokine secretion 
[85]. Furthermore surgical manipulation stimulates aggregation of neutrophils and macrophages 
and secretion of pro-inflammatory mediators such as IL-6 and prostaglandins. NK cell activity is 
known to be suppressed immediately after surgery and remains decreased several days. This 
suppression has been shown to be more prolonged in individuals with cancer [83]. The extent of 
this alteration of immune function is thought to be proportional to the magnitude of surgical 
trauma [86].  
There is some evidence that imbalances of the immune system during or after surgery 
significantly contribute to the development of sepsis and multi organ dysfunction syndrome 
(MODS). Characterizing the status of the perioperative immune function is therefore of great 
interest. Perioperative interventions aimed at preventing these imbalances might improve patient 
outcome and reduce morbidity as mortality during or after surgery.  
 
1.3.3 Pain and immunity 
The pathway from pain to immune response seems to be extremely complex. If confronted with 
pain the immune system firstly answers with acute inflammation. Its primary task is to detect, 
contain and eliminate invading microbes (bacteria, fungi, viruses) quickly, and it does so by 
relying on macrophages and mast cells that are stationed strategically in the tissues and 
circulating neutrophils to signal and engage foreign genomes. This defence becomes systemic in 
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major surgery and its severity is proportional to the degree of tissue injury and the length of 
surgery. If the acute inflammation is excessive organ damage or even death can follow. Locally 
surgical manipulation causes the release of immune mediators, like substance P, prostaglandins 
and cytokines, which can subsequently induce pain feeling and download the threshold of pain 
(hyperalgesia and allodynia). Meanwhile the sensory signal of this nociception is submitted to 
the brain via the dorsal horn of the spinal cord. Centrally, the activation of the central nervous 
system (CNS) and hypothalamic- pituitary- adrenal (HPA) axis pathways results the releasing of 
the stress hormones including the corticosteroid from the adrenal cortex. The hypothalamus also 
activates the sympathetic nervous system, thereby resulting in the secretion of epinephrine from 
the adrenal medulla and the release of norepinephrine from sympathetic terminals. All these 
stress hormones are considered having an inhibition on the immune response: inhibiting the 
antigen presentation [87], suppressing APC and Th1 production and up-regulating Th2 cytokine 
production [88]. In this phase, monocytes are tolerant to endotoxin and do not secrete normal 
amounts of pro-inflammatory cytokines [89], antigen presentation is suppressed, natural killer 
cell function is compromised (e.g., decreased interferon-γ(IFN-γ) production) [90], the total 
number of blood lymphocytes is decreased [91]. Furthermore, evidence suggests that proportion 
of the T cell subsets changed too [92]. The suppression of the adaptive immunity after pain stress 
is generally related to the increased susceptibility to sepsis, SIRS and tumour recurrence both in 
short and long term [93]. 
Therefore, an optimal pain management might provide an available method to protect the 
patients from not only the feeling of pain but also the following immune impairment and finally 
ameliorate the perioperative outcome. From this point of view, the understanding of the 
relationship between pain management and immune function, especially with regard T-Helper 
cells, seems to be of central interest. 
 
1.3.4 Perioperative pain managements 
Standard pain managements after major surgery include either intravenous infusion of opioids or 
epidural nerve block with local anaesthetics. Both techniques are proved to provide satisfactory 
results. 
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1.3.4.1 Intravenous analgesia 
Opioids have been indispensable components of intravenous anaesthesia for over 100 years. 
Common opioids include Morphine and its derivates: fentanyl, remifentanil, alfentanil, sufentanil. 
It has been known for many years that opioids suppress hypothalamic and pituitary hormone 
secretion. In lower abdominal surgery, fentanyl 15 μg/kg was sufficient to inhibit cortisol and 
glucose responses [94]. In upper abdominal surgery, clinical doses of fentanyl have been found 
to be relatively ineffective in preventing the complete stress response to surgical stress [95]. In 
addition, Opioids are generally thought to moderately suppress the activity of natural killer (NK) 
cells both in animal and in human [96-99]. However, Cronin et al in recent studies demonstrated 
that an 8-h infusion of remifentanil did not affect NK cell activity in normal volunteers differing 
from all other opioids [100]. The impact of opioids on the immune system is still controversial. 
More evidences are needed to clear the effects of intravenous analgesia on perioperative immune 
response.  
Remifentanil is a newer synthetic opioid which was first described in 1990 and was approved for 
clinical use in 1996. It acts on µ receptors systematically and is metabolized by non-specific 
tissue and plasma esterases, thus providing a good tolerance for patients with liver or renal 
failure. Remifentanil is particularly suited for Total Intravenous Anaesthesia (TIVA) according to 
its rapid onset and short duration of action. The potency of remifentanil is similar to fentanyl. 
Like fentanyl and its other derivates, remifentanil offers a remarkable hemodynamic stability. 
Bradycardia and hypotension can be seen only with higher dosage, which can be avoided by 
slowing administration and/or increasing preload. The combination of remifentanil and propofol 
for TIVA has been successfully used for a variety of operations, including coronary artery bypass 
graft (CABG) [101, 102]; major thoracic [103], abdominal [104], and orthopaedic [105] 
procedures in both adults and children.  
 
1.3.4.2 Epidural analgesia 
Epidural analgesia is reached by injection of drugs through a catheter placed into the epidural 
space. The injection can cause both a loss of sensation (anaesthesia) and a loss of pain 
(analgesia), by blocking the transmission of signals through nerves in or near the spinal cord.
The epidural space lies between the spinal meninges and the vertebral canal, surrounding the 
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dura mater (posteriorly, laterally, and anteriorly). It contains a rich venous plexus, fatty 
connective tissue, lymphatics and nerve roots, on which the local anaesthetic acts. Recently 
epidural analgesia is more frequently employed in conjunction with general anaesthesia, so 
called combined anaesthesia.  
When epidural analgesia is performed in the thoracic region, it is called thoracic epidural 
anaesthesia (TEA) or thoracic epidural block (TEB). TEA is technically more difficult to 
accomplish than lumbar blocks because of the anatomy of vertebrae (greater angulation and 
marked overlapping of the spinous processes in thorax). In spite of the risks, many evidences 
demonstrated that TEA provided better heart-perfusion, less oxygen demand with sympathetic 
nerve block [106-108] and resulted in less postoperative complications [109] and lower mortality 
[110].  
Many investigators also reported that epidural analgesia had advantageous effects on the immune 
response to surgical stress, including the reduction of NK cell activity suppression [111], and 
maintenance of Th1 cell numbers [112]. Beilin et al found that compared with intravenous 
analgesia, postoperative epidural analgesia provided a better pain relief, more IL-1 and IL-6 
production, reduced suppression of lymphocyte proliferation and attenuated pro-inflammatory 
response [113]. Volk’s study also revealed that postoperative epidural analgesia preserved 
lymphocyte rather than monocytes function compared with intravenous analgesia, which may be 
benefit to resist the infection [84]. Kawasaki et al. studied the production of TNF-α, IL-10, 
monocytes HLA-DR expression and mCD14 expression of patients with intravenous and 
epidural analgesia respectively, but no difference was found till the postoperative day 4 [114]. 
Ropivacaine is a long-acting amide local anaesthetic and is mainly metabolized in the liver. It is 
widely applied for epidural anaesthesia and peripheral nerve block during surgery, as well as for 
postoperative analgesia. The major attractive advantage of ropivacaine is that it has similar 
potency to Bupivacaine with regard to pain relief, but causes less CNS-toxicity, cardio-toxicity 
and motor block. As far, there is no evidence if the distribution of ropivacaine in circulation has a 
direct systematic effect on the human immune system. However, it is clear that the concentration 
in systemic circulation is lower than that in local epidural room after epidural anaesthesia. 
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1.4 Aims of the study 
The most important postoperative complication in patients undergoing lung surgery is 
postoperative pneumonia. T1/T2 balance is well-known to be suppressed within the first three to 
five days after major surgery. Recent evidences revealed that the development of Th cells was 
controlled by its specific transcription factors. Although perioperative immune function has been 
widely studied by the measurement of Th cells and its cytokines, the role of Th specific 
transcription factors in perioperative immune response is still unclear.  
Surgery induced pain is a major stressor which influences the immune response. A good pain 
management can be helpful for maintaining immune homeostasis and improving surgery 
outcomes. Clinical common used pain managements include intravenous analgesia and epidural 
analgesia. There is some evidence that epidural analgesia is able to maintain the perioperative 
immune balance better than intravenous analgesia does. But this conclusion is still not coincident. 
T-bet is the specific transcription factor of Th1-response and GATA3 is the regulating 
transcription factor of Th2-response. In vitro evidence is documented that SOCS1 negatively 
modulates the Th1 development and SOCS3 inhibits the Th2 development [70]. However the in 
vivo transcription factors’ answer in a perioperative setting is unknown. 
 
Therefore, the aim of this prospective, randomised, double blinded, controlled trial was to  
1. investigate if epidural and intravenous analgesia have different impacts on the expression of 
Th cell transcription factors (primary outcome measure);  
2. investigate if the Th1 negative regulator SOCS1 has a corresponding alteration to the Th1 
positive regulator T-bet in perioperative immune response, as well as SOCS3 to GATA3 










2.1 Study design: 
This study was conducted between January 2005 and June 2007 in a prospective, randomised, 
double-blinded controlled design at the Klinik für Anästhesiologie mit Schwerpunkt operative 
Intensivmedizin of the University Hospital Charité, Charité Virchow-Klinikum and Campus 
Charité Mitte, Charité - Universitätsmedizin Berlin. It was approved by the local ethics 
committee (No. EA 1/175/05), the Federal Institute for Drugs and Medical Devices (BfArM) and 
the Federal Opium Agency (BOPST). Quality of randomization and double-blind procedure were 
controlled by the Koordinierungszentrum Klinische Studien Charité (KKS Charité). 
 
2.2 Patient selection and exclusion criteria: 
One-hundred thirteen consecutive patients scheduled for elective lung surgery at the Charité 
University Hospital were screened for eligibility. All patients were randomized in a double-blind 
fashion to three groups. One of these groups was not considered in this thesis. According to the 
clinical trial protocol patients meeting at least one of the following exclusion criteria were not 
admitted to this study: 1) age under eighteen years, 2) guardianship/conservatorship, 3) refusal to 
participate in the study, 4) pre-existing alterations of the immune system such as infections 
meeting criteria of the Center for Disease Control and Prevention (CDC) or treatments and 
disorders with direct influence on the immune system such as immune modulating therapy or 
adrenal pathology, 5) pregnancy, 6) contraindications for epidural catheter insertion, 7) 
contraindications for ropivacaine or remifentanil application, 8) pre-existing treatment with the 
above-mentioned trial drugs or drugs belonging to the same pharmacological class, 9) class III or 
higher according to The New York Heart Association (NYHA) Functional Classification, 10) 
myocardial infarction in the previous eight weeks before surgery. In total, 40 patients remained 
in the analysis of this thesis.  
Each participant gave written informed consent. Patients were randomly assigned to one of the 
three groups, while one arm featuring additional clonidine treatment was not considered in this 
thesis: 1) intravenous remifentanil analgesia during the operation and 2) thoracic epidural block 
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with ropivacaine during the operation (Tab. 2). 










10 ml syringe for  
epidural bolus application 
 
10 ml of placebo 
instead of 
ropivacaine 








10 mg of 
remifentanil diluted 
with 50 ml normal 
saline 
50 ml of placebo 
instead of 
remifentanil 




50 ml of placebo 
instead of 
ropivacaine 
50 ml of 
ropivacaine 0.2% 
(2 mg/ ml) 
 
2.3 Anaesthesia management 
All anaesthetists who performed anaesthesia and/or collected blood samples were blinded to both 
groups. Anaesthesia protocols were based on the clinics internal standard operating procedures 
(“Check-up Anästhesiologie”, Spies et al).  
 
2.3.1 Premedication: 
Midazolam (Dormicum®, Hoffman-La Roche AG Germany) at a dosing of 0.15 mg•kg-1 was 
administered orally 30 minutes prior to arrival at the anaesthesia induction room. Fasting began 6 
hours before induction and clear fluids have been given up to 2 hours before anaesthesia. 
 
2.3.2 Placement of epidural catheter 
On arrival in the induction room an 18 gauge intravenous catheter was placed and an infusion of 
500 ml Ringer’s Lactate solution was started. Meanwhile 5 lead ECG, NIBP (non-invasive blood 
pressure), SpO2 (oxygen saturation) and RR (respiration rate) were monitored continuously.  
After local infiltration of 5 ml 1 % Lidocaine, thoracic epidural puncture was performed in the 
operating room by median approach and loss of resistance technique at a level between Th4 and 
Th7. After 5 cm catheter insertion into the epidural space an accidental subdural catheterization 
Charité Universitätsmedizin Berlin                                                                                                                Methods 
 16
was ruled out by injecting the standard test dose of 3 ml isobaric bupivacaine 0.5%.  
 
2.3.3 Induction of anaesthesia 
An arterial catheter was placed in the radial artery for continuous invasive blood pressure (IBP) 
monitoring and blood gas analysis. After preoxygenation with 100% of oxygen by means of 
facemask, anaesthesia was inducted. The standardized regimen of induction included Fentanyl 
(Fentanyl Janssen®, Janssen-Cilag, Neuss, Germany) 0.1-0.2mg, Propofol (Propofol fresenius®, 
Fresenius Kabi, Germany) 2mg/kg, and Cisatracurium (Nimbex®, GlaxoSmithKline, UK) 
0.15mg/kg. Fentanyl was given prior to Propofol. As soon as patients lost their eyelash reflex 
and stopped spontaneous breathing, mask ventilation was started and cisatracurium administered. 
Oral tracheal intubation was performed with double-lumen endobronchial tube (Broncho-cath TM 
Left, Nellcor, USA, Boulder; size: female 37 Ch, male 39 Ch). Position was verified and 
corrected by fiberoptic bronchoscopy if necessary. Finally, a 7.0 F triple-lumen central venous 
catheter was placed in the subclavian vein if required. 
 
2.3.4 Maintenance of anaesthesia 
Patients were pressure controlled ventilated using an Aestiva/5® anaesthesia machine (Datex-
Ohmeda, GE Healthcare P.O. Box 7550 Madison, WI 53707-7550, USA). During one-lung 
ventilation (OLV) patients were ventilated in terms of lung protective ventilation with 5 ml/kg 
body weight and positive end-expiratory pressure (PEEP) of 5 cmH2O. Normocapnia was 
maintained by adapting respiratory rate. Initial inspiratory oxygen fraction (FiO2) of 1.0 was 
reduced according to blood gas analysis.
Continuous infusion of 6-8mg/kg/h Propofol was initiated immediately after induction and 
intraoperative analgesia was performed double-blind either with remifentanil continuously i.v. or 
ropivacaine continuously epidurally. 
Remifentanil was infused at 0.2-0.4 μg/kg/min and ropivacaine at 6 - 10 ml/h until the end of 
surgery. Anaesthesia was stopped 3 minutes prior to the end of the operation and all patients 
received an i.v. morphine bolus of 0.1mg/kg. Extubation was conducted in the operating room. 
Continuous postoperative analgesia with ropivacaine 0.2% via peridural catheter was performed 
on all patients. (Fig. 3). 
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2.4 Sample collection 
Blood samples (BS) were collected on day of surgery and the first three postoperative days at 
morning rounds (Fig. 2). BS 2 and BS 3 were collected during lung resection and on arrival at 
the intensive care unit (ICU). Each time, 2.5ml blood was drawn from a central or peripheral 
vein using BD Vacutainer® Safety-Lok™ Blood Collection Set (Becton Dickinson GmbH, 
Germany, Heidelberg) and softly injected into a PAXgene Blood RNA Tube (PreAnalytiX 
GmbH, Germany). PAXgene Blood RNA Tubes then were gently inverted 10 times and placed 
upright at room temperature for at least 2 hours. After that, tubes were transferred to -20 °C for 











 prod               iop  opd    1st postopd   2nd postopd     3rd ostopd 
Figure 2: Schema of the study protocol  
BS: blood sample; TEB: thoracic epidural block; POD: postoperative day; ICU: intensive care unit; prod = pre-
operative day, iop = intra-operative, opd = operation day, postopd = post-operative day 
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Table 3: Instruments used in the study 
7500 Realtime PCR system ABI 
96 well Opital Plate ABI 
Biometra Trio-Thermoblock Biotron 
Centrifuge 5424 Eppendorf 
Centrifuge 5804 Eppendorf 
Heraeus Multifuge 3L-R Thermo Scientific 
Mastersycler personal Eppendorf 
MicroAmp Optical Tubes and Caps ABI 
Pipet 0.5-5000μl Eppendorf 
PCR reaction tubes 0.5ml Eppendorf 
Sterile, RNase-free pipet tips with filter Greiner Bio One 
Thermomixer Compact Eppendorf 
Vortex mixer 7-2020 Neolab 
 
2.5.1.2 Chemicals, kits 
Table 4: The chemicals and kits used in real time PCR 
Ampuwa Fresenius Kabi 
DNase I Invitrogen 
M-MLV Reverse-transcriptase Promega 
Oligo (dT) Primer Promega 
Ethanol (analytical pure)  
PAXgene Blood RNA kit PreAnalytiX  
RNase Inhibitor  
TagMan universal PCR Master Mix Roche 
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2.5.1.3 Primer used in relative Quantitation real time PCR 
Table 5: Sequence of primers: 
Symbol Sequence 
forward primer:5′-CAA CAC AGG AGC GCA CTG G-3′ T-bet 
reverse primer :5′- CCC CCT TGT TGT TTG TGA GCT-3′ 
forward primer: 5′- CCT CAT TAA GCC CAA GCG AAG-3′ GATA3 
reverse primer : 5′-TTG GCA TTC CTC CTC CGA AGT-3′ 
forward primer:5′-AAG TGG CCC GGA TGT GAG A-3′ FOXP3 
reverse primer :5′- CAT TGT GCC CTG CCC TTC T-3′ 
forward primer:5′CCG CGA CTA CCT GAG CTC CTT-3′ SOCS1 
reverse primer :5′AGT TAA TGC TGC GTG CAC GG-3′ 
forward primer:5′-CTT TCT GAT CCG CGA CAG CT-3′ SOCS3 
reverse primer :5′-TCA CAC TGG ATG CGC AGG T-3′ 
forward primer: 5′-AGT CTG GCT TAT ATC CAA CAC TTC G-3′ HPRT1 
reverse primer :5′- GAC TTT GCT TTC CTT GGT CAG G-3′ 
ROR-γ This primer was bought from ABI, unlike others are designed by us 
 
 
2.5.1.4 Fluorogenic Probe used in relative Quantitation real time PCR 
Table 6: Sequence of probes: 
Symbol Sequence 
T-bet 5′-CAC CTG TTG TGG TCC AAG TTT AAT CAG CAC C-3′ 
GATA3 5′-TCC TGT GCG AAC TGT CAG ACC ACC AC -3′ 
FOXP3 5′- ACT TCC TCA AGC ACT GCC AGG CGG-3′ 
SOCS1 5′-TTC CAG ATT TGA CCG GCA GCG C-3′ 
SOCS3 5′-CCA GCG CCA CTT CTT CAC GCT Cag-3′ 
HPRT1 5′- TTT CAC CAG CAA GCT TGC GAC CTT GA-3′ 
ROR-γ This probe was bought from ABI, unlike the others designed by us 
 
2.5.2 RNA isolation 
Total RNA of each blood sample was contracted by PAXgene Blood RNA Kit according to the 
manufacturer’s instruction. In brief, after overnight thaw, samples were centrifuged and washed 
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twice. Pellets of blood were then incubated with proteinase K to digest the protein. Digested 
solutions were transferred into the PAXgene Shredder to homogenize cell lysate and residual cell 
debris was removed by centrifuging again. Subsequently, cell lysate was transferred into a 
PAXgene RNA spin column to bind to the PAXgene silica membrane. After several efficient 
wash steps, total RNA was finally eluted in elution buffer and stored at -80 °C waiting for cDNA 
synthesis.  
 
2.5.3 cDNA template synthesis (reverse transcription) 
Total RNA was reverse-transcribed using M-MLV reverse transcriptase and oligo (dT) primer in 
a final volume of 40μl (Table 7). First, RNA and oligo (dT) primer were pre-incubated at 75 °C 
for 10 min, then for 30 min at 37 °C with prepared compound B and further for 60 min at 42 °C 
with compound C. RNA samples were then treated with RNase-free DNase I before reverse 
transcription to eliminate contaminating genomic DNA. The synthesized cDNA was stored at  
-20°C. 
Table 7: Standard reactions and procedure of cDNA synthesis 
Segment Temperature °C Time (min) Compound reactions Volume 
1 75 10 total mRNA 21.5ul 
   
A
Oligo(dT)-Primer 2 ul 
2 37 30 Reaction Buffer 8ul 
   dNTP mix 4 ul 
   RNase Inhibitor 0.5 ul 
   DNase 2ul 
3 75 5 
B
--- --- 
4 42 60 Reverse-transcriptase 1 ul 
   RNase Inhibitor 1 ul 
5 94 5 
C
--- --- 
Total  110   40 ul 
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2.5.4 Relative quantitation real time PCR 
Gene expression of transcription factors was measured in duplicate by relative quantitative real 
time reverse-transcription polymerase chain reaction (relative qRT-PCR) with the use ofABI 
Prism 7500 Sequence Detection System (ABI 7500 SDS, Applied Biosystems, USA, Foster City). 
The specific primer and internal fluorogenic probe of ROR-γ was bought from ABI. Others were 
designed by using Primer Express 2 and synthesized by Metabion GmbH (Metabion, Germany, 
Martinsried) (Table 5 and 6). Reporter dye used in real time PCR was FAM (6-
carboxyflurorescein) and quencher dye was TAMRA N,N,N′,N′-tetramethyl-6- 
carboxyrhodamine). Thermal cycling conditions were designed as follows: initial denaturation at 
95°C for 10 min, followed by 40 cycles of 95°C for 15 s and 60°C for 1 min (Table 9). Study 
transcription factors, T-bet, GATA3, ROR-γ, FOXP3, SOCS1 and SOCS3, were set as target 
genes and HPRT1 (Hypoxanthine Phosphoribosyltransferase 1) as endogenous control. 
Fluorescent measurements, which reflect gene expression, were recorded during each annealing 
step. At the end of each PCR run, fluorescent data were automatically analyzed by ABI system 
and plotted against time forming an amplified curve. NTC (cDNA replaced by water as blank 
control) was performed to check for non-pollution from reaction in each plate.  
Table 8: Standard qRT-PCR reaction 
Compound Volume 
cDNA 3.25ul 




Table 9: Standard program of qRT-PCR 




1 AmpErase® UNG 
Activation 
50 2:00 
2 DNA Polymerase 
Activation 
95 10:00 
Melt 95 0:15 3 
(each of 40 
Cycles) 
Anneal/Extend 60 1:00 
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2.5.5 Calculation of relative quantitation of target gene expression using 2-ΔΛCT method 
The 2-ΔΛCT method was used to evaluate expression levels of target transcription factors at each 
time point [115]. Briefly, baseline and threshold value (CT) of each sample was automatically 
created by SDS (Sequence Detective Software, Applied Biosystems, version 1.3.1). The level of 
target transcription factor was normalized to a calibrator in each case. The calibrator chosen was 
the sample collected before the operation. Final results were expressed as Rn (n-fold change) in 
gene expression relative to endogenous gene HPRT1 and calibrator as follows: Rn = 2-(△Ct sample-
△Ct calibrator), where △Ct values of sample and calibrator were determined by subtracting the 
average Ct value of the target gene transcript from the average Ct value of each sample’s HPRT1. 
All measurements were made in duplicate and results were only accepted if duplicate pairs 
differed by less than 0.5 cycles. Final results were transferred into SPSS for further statistical 
analysis.  
 
2.6 Statistical analysis 
Results were expressed as arithmetic mean ± standard error of mean (SEM) [no rejection of 
normal distribution] or median and (25% - 75% quartiles) [non-symmetrically distributed 
observations], respectively. Absolute and relative frequencies have been used for categorical and 
dichotomous variables. In dependence on the proved distributions, Student’s t-test or the non-
parametric Mann-Whitney U-test were applied for inter-group comparisons. Frequencies were 
tested by Fisher’s exact test. In case of large differences in the sample sizes and/or data with ties 
and/or sparse data in contingency tables, exact versions of the tests were applied (StatXact 5®, 
Cytel Software Corp. Cambridge, MA 02139 USA, 2001). The differences between groups (such 
as treatment with remifentanil or ropivacaine) with respect to various clinical endpoints were not 
only univariately proved but also multivariately by using the non-parametric multivariate 
analysis of variance for repeated measurements (Brunner, E., Domhof, S. and F. Langer (2002): 
Nonparametric Analysis of Longitudinal Data in Factorial Experiments. Wiley & Sons, New 
York). Therefore, we have compared all the time points simultaneously on the corresponding 
response curves. Intra-group differences (between certain time points) were tested by means of 
the non-parametric Wilcoxon rank-sum test for paired observations. Correlations between 
selected clinical parameters were estimated and tested (against H0: ρ = 0) by Spearman’s rank 
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correlation coefficient. A two-tailed p-value < 0.05 was considered statistically significant. All 
tests should be understood as constituting exploratory data analysis, such that no adjustments for 
multiple testing have been made. Numerical calculations were performed with SPSS, Version 15, 
Copyright© SPSS, Inc., Chicago, Illinois 60606, USA, SAS, Version 9.1, Copyright© by SAS 
Institute, Inc., Cary, NC, USA, and StatXact 6®, CYTEL Software Corp., Cambridge, MA 
02139,USA.
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3. Results 
 
3.1 Demographics and clinical characteristics 
40 Patients were randomly assigned to one of the two groups as shown in figure 3.  
 





Patients allocated to 
the remifentanil group: 
n=20 
Patients allocated to 
the ropivacaine group: 
n=20 
Met inclusion criteria but 
declined enrollement: 
n=5 
Figure 3: Flow of participants 
 
Basic demographics and basic characteristics of both groups were equally distributed as shown 
in table 10. 
Clinical characteristics are shown in table 11. All items were comparable between groups, no 
significant differences could be found. Six patients of the remifentanil group and 3 patients of 
the group receiving ropivacaine underwent Video Assisted Thoracic Surgery (VATS). No 
significant differences were found for anaesthesia duration, ICU-stay and re-surgery rate and no 
patient showed SIRS symptoms. 
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Age ( Years ) 66.5 (50.0-70.5) 65.5 (63.0-70.5) 0.429 
Sex (Male/Female), No. § 13/7 (65/35 %) 16/4 (80/20 %) 0.300 
BMI (kg/m2) 26.37 (21.56-29.77) 26.56 (22.16-30.08) 0.708 
ASA(I/II/III/IV), No. § 0/8/12/0 (0/40/60/0 %) 0/8/12/0 (0/40/60/0 %) >=0.999 
Pre-existing cardiovascular disease, No.§ 11 (55%) 14 (70%) 0.514 
Pre-existing Beta-blocker therapy, No. § 7 (35%) 8 (40%) >=0.999 
Pre-existing anti-diabetic therapy, No. § 3 (15%) 3 (15%) >=0.999 
Current Smoking, No. § 3 (15%) 7 (35%) 0.273 
Data are presented as median (quartiles 25-75) or No. (frequency) 
BMI: Body Mass Index; ASA: American Society of Anaesthesiologists 
Two sided P values are based on the Mann-Whitney U test. 










Duration of operation (min, mean ± SEM) 158±21 146±21 0.678 
Anaesthesia duration (min, mean ± SEM) 232±20 215±17 0.521 
VATS, No § 6 3 0.451 
Re-surgery, No § 2 1 >=0.999
ICU stay (day, mean ± SEM)  1.85±0.67 1.70±0.74 0.841 
VATS: video assisted thoracic surgery, SEM: Standard Error Mean 
Two sided P values are based on the student t test. 
§: Two sided P values are based on the Fisher’s chi-square test. 
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3.2 T-bet expression 
We detected expression of mRNA for T-bet in all samples using relative quantitative real time 
PCR (relative qRT-PCR). According to the 2-ΔΛCTmethod we used, the final acquired value (Rn) 
represents the n-fold change of T-bet expression in relation to preoperative baseline values (prod) 
as shown in table 12. 
 
Table 12: Cumulative (both groups) T-bet expression in quantitative real time PCR 
iop = intra-operative, opd = operation day, postopd = post-operative day 
 Percentile iop opd 1 postopd 2 postopd 3 postopd 
25 % 0.667 0.837 0.211 0.246 0.398 
median 1.021 1.608 0.422 0.586 0.563 
T-BET 
[Rn] 
75 % 1.944 3.244 0.983 1.186 0.825 
T-bet expression in each group as represented in figure 4 shows no significant difference 
between groups in analysis of variance (p= 0.313). 
 
Figure 4: n-fold 
change of T-bet 
expression related to 
preoperative baseline 
values in both 
groups. Prod = pre-
operative day, iop = 
intra-operative, opd 
= operation day, 
postopd = post-
operative day 
Cumulative alterations of T-bet expression in all patients for the time point end of surgery in the 
Wilcoxon rank-sum test for paired observations reached a two-sided significance (p= 0.001) for 
the time point opd related to preoperative baseline (prod). The remifentanil group itself showed a 
significant increment as well for the time point opd (p= 0.016), while the ropivacaine group 
showed no significance in the non-parametric Wilcoxon rank test (p= 0,058). 
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3.3 GATA3 expression 
We detected expression of GATA3mRNA using relative qRT-PCR. According to the 2-ΔΛCT 
method, the final acquired value (Rn) represents the n-fold change of GATA3 expression in 
relation to preoperative baseline values (prod) as shown in table 13. 
 
Table 13: GATA3 expression in quantitative real time PCR 
iop = intra-operative, opd = operation day, postopd = post-operative day 
 Percentile iop opd 1 postopd 2 postopd 3 postopd 
25 % 0.687 0.544 0.247 0.285 0.373 
median 1.008 1.025 0.480 0.572 0.653 
GATA3 
[Rn] 
75 % 1.266 1.576 0.775 1.021 1.043 
GATA3 expression in both groups is represented in figure 5. Statistically, differences in the 
cumulative course are not significant (p= 0.164). 
 
Figure 5: n-fold 
change of GATA3 
expression related to 
preoperative baseline 
values in both 
groups. Prod = pre-
operative day, iop = 
intra-operative, opd 




Cumulative expression for all patients at the time point opd in the Wilcoxon rank-sum test was 
not significant for the GATA3 curve (p= 0.826). The remifentanil group itself (p= 0.215) as well 
as the ropivacaine group itself (p= 0.286) showed no statistical significance. 
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3.4 FOXP3 expression 
We detected expression of FOXP3 mRNA using relative qRT-PCR and the 2-ΔΛCTmethod. The 
final acquired value (Rn) represents the n-fold change of FOXP3 expression in relation to 
preoperative baseline values (prod) as shown in table 14. 
 
Table 14: FOXP3 expression in quantitative real time PCR 
iop = intra-operative, opd = operation day, postopd = post-operative day 
 Percentile iop opd 1 postopd 2 postopd 3 postopd 
25 % 0.547 0.486 0.310 0.358 0.460 
median 0.940 0.813 0.690 0.665 0.673 
FOXP3 
[Rn] 
75 % 1.363 1.421 1.093 1.210 1.150 
FOXP3 expression in both groups is represented in figure 6. The differences in the cumulative 
course are not of statistical significance (p= 0.425). 
 





values in the two 
Alteration of expression in all 40 patients at time point opd in the Wilcoxon rank-sum test for 
paired observations showed no two-sided asymptotic significance (p= 0.850) in relation to 
preoperative baseline values. The remifentanil group itself (p= 0.913) as well as the ropivacaine 
group itself (p= 0,647) showed no statistical significance for time point opd. 
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3.5 ROR-γ expression 
We detected expression of mRNA for ROR-γ in all samples using relative qRT-PCR. According 
to the 2-ΔΛCT method, the final acquired value (Rn) represents the n-fold change of ROR-γ 
expression in relation to preoperative baseline values (prod) as shown in table 15. 
 
Table 15: GATA3 expression in quantitative real time PCR 
iop = intra-operative, opd = operation day, postopd = post-operative day 
 Percentile iop opd 1 postopd 2 postopd 3 postopd 
25 % 0.654 0.508 0.324 0.327 0.388 
median 1.033 0.971 0.498 0.585 0.722 
ROR-γ 
[Rn] 
75 % 1.482 1.622 1.058 1.105 1.087 
ROR-γ expression in the two groups is represented in figure 7. The differences in the cumulative 
course are not of statistical significance (p= 0.651). 
 
Figure 7: n-fold 
change of ROR-γ 
expression related to 
preoperative baseline 
values in both 
groups. Prod = pre-
operative day, iop = 
intra-operative, opd 




Cumulative expression of all patients at time point prod in the Wilcoxon rank-sum test was not 
significant for the ROR-γ curve (p= 0.675). The remifentanil group itself (p= 0.446) as well as 
the ropivacaine group itself (p= 0.877) showed no statistical significance. 
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3.6 SOCS1 expression 
Expression of SOCS1 mRNA in all samples using relative qRT-PCR results in the n-fold change 
in relation to preoperative baseline values (prod) as shown in table 16. 
Table 16: SOCS1 expression in quantitative real time PCR 
iop = intra-operative, opd = operation day, postopd = post-operative day 
 Percentile iop opd 1 postopd 2 postopd 3 postopd 
25 % 0.587 0.522 0.098 0.187 0.180 
median 0.972 0.895 0.326 0.360 0.477 
SOCS1 
[Rn] 
75 % 1.249 2.321 0.807 0.986 1.140 
SOCS1 expression in both groups is represented in figure 8. Differences in the cumulative course 
are not of statistical significance (p= 0.517). 
 
Figure 8: n-fold 
change of SOCS1 
expression related to 
preoperative baseline 
values in both 
groups. Prod = pre-
operative day, iop = 
intra-operative, opd 
= operation day, 
postopd = post-
operative day. 
Cumulative expression of all patients at time point prod in the Wilcoxon rank-sum test was not 
significant for the SOCS1 curve (p= 0.499). The remifentanil group itself (p= 0.586) as well as 
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3.7 SOCS3 expression 
The expression of mRNA for SOCS3 in all samples using relative qRT-PCR results in the n-fold 
changes in relation to preoperative baseline values (prod) as shown in table 17. 
 
Table 17: SOCS3 expression in quantitative real time PCR 
iop = intra-operative, opd = operation day, postopd = post-operative day 
 Percentile iop opd 1 postopd 2 postopd 3 postopd 
25 % 1.11 3.50 2.35 1.30 1.19 
median 2.51 8.59 4.63 2.63 3.03 
SOCS3 
[Rn] 
75 % 8.00 24.25 8.30 5.65 4.80 
SOCS3 expression in the two groups is represented in figure 9. The differences in the cumulative 
course are not of statistical significance (p= 0.177). 
 
Figure 9: n-fold 
change of SOCS3 
expression related to 
preoperative baseline 
values in both 
groups. Prod = pre-
operative day, iop = 
intra-operative, opd 
= operation day, 
postopd = post-
operative day. 
Alteration of SOCS3 expression of all 40 patients at the end of surgery in the Wilcoxon rank-
sum test for paired observations reached a two-sided high significance (p < 0.0001) for the time 
point prod related to preoperative baseline values. The remifentanil group itself (p < 0.0001) as 
well as the ropivacaine group itself (p < 0.0001) showed significant increments for the time point 
prod. 
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3.8 Correlation between T-bet and SOCS1 
In Spearman's rank correlations (Spearman's rho), the correlation coefficient between T-bet and 
SOCS1 was highly significant for all time points except for 1 postopd (p= 0.050) as shown in 
table 18. 
 
Table 18: Spearman’s rank correlations T-bet / SOCS1 
iop = intra-operative, opd = operation day, postopd = post-operative day. 
 
 
Correlation between T-bet and SOCS1 
 
Correlation coefficient 0.546 iop 
 
 2-sided significancy p < 0.0001 
Correlation coefficient 0.514 opd 
 
 2-sided significancy p= 0.001 
Correlation coefficient 0.328 1 postopd 
 
 2-sided significancy p= 0.050 
Correlation coefficient 0.488 2 postopd 
 
 2-sided significancy p= 0.002 
Correlation coefficient 0.582 3 postopd 
 
 2-sided significancy p < 0.0001 
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3.9 Correlation between GATA3 and SOCS3 
Spearman's rank correlation coefficient shows no correlation at any time point between GATA3 
and SOCS3 as reported in table 19. 
 
Table 19: Spearman’s rank: correlations GATA3 / SOCS3 
iop = intra-operative, opd = operation day, postopd = post-operative day. 
 
 
Correlation between GATA3 and SOCS3 
 
Correlation coefficient -0.180iop 
 
 2-sided significancy p= 0.285
Correlation coefficient -0.278opd 
 
 2-sided significancy p= 0.101
Correlation coefficient 0.2371 postopd 
 
 2-sided significancy p= 0.165
Correlation coefficient 0.2922 postopd 
 
 2-sided significancy p= 0.076
Correlation coefficient 0.2393 postopd 
 
 2-sided significancy p= 0.160
 
 





The most important results of this study were: 
1) Immediately after surgery T-bet expression is significantly increased in the remifentanil 
group but not in the ropivacaine group. All other transcription factors did not differ 
between groups. 
2) The SOCS3 expression is significantly increased in both the remifentanil and the 
ropivacaine group. The n-fold change of T-bet expression levels significantly correlates 
with the n-fold change of SOCS1 expression levels at all time points except for the first 
postoperative day, which nevertheless shows a clear trend. 
 
4.1 T-bet expression 
In the present study we found that the expression of T-bet mRNA can be divided into 2 stages: 
during surgery and during the postoperative phase. T-bet expression increased during surgery 
and reached a significant maximum at the end of the operation. 
Very little is known about T-bet expression in a perioperative setting. Additionally, as the 
cytokine signalling downstream of the transcription factors has not been measured in this study 
the interpretation of our results has to remain on a speculative level. 
Following hepatobiliary pancreatic surgery, T-bet mRNA expression level was not changed after 
surgery but was significantly higher on postoperative day 3, 7, and 14 in patients with 
postoperative infection (P < 0.05) [116]. 
Besides prevention of infections, functional Th1 cells are required for surgical adhesion 
formation in a murine model [117]. 
In contrast, chronic morphine treatment resulted in a decrease in T-bet mRNA levels [118]. On 
one hand this might be indicative of a better maintained immune reactivity with the ropivacaine 
group in our setting. On the other hand, different regulations in acute surgical settings might be 
seen and this might result from the better maintained immune reactivity if pain is treated pre-
emptively. It was shown previously in our group that remifentanil maintains immune reactivity 
during surgery better than fentanyl did [119]. 
In conclusion, the different T-bet response during surgery could either be in favor of remifentanil 
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to defend infections after surgical stress and to induce surgical adhesion formation, or could be 
an indicator of a more stressful response with remifentanil than with ropivacaine due to 
intraoperative increased stress and therefore postoperative inflammation.  
It can be speculated that the assessed increase of T-bet is due to an alteration of IFN-γ and 
macrophages, both of which are important components in the early pro-inflammatory response 
following operation. Roumen and other researchers, by measuring macrophage secreted 
cytokines IL-1β and IL-6, demonstrated that macrophage activation significantly increased in 
major surgery [120, 121]. Macrophages present antigens to Th1 cells via MHC II and induce 
their proliferation. In addition macrophages produce IL-12, which binds to IL-12 receptors of 
Th1 cells. Both pathways have the ability to boost transcription of T-bet, which could 
subsequently induce IFN-γ transcript and synthesis. Furthermore, IFN-γ can activate effector-
macrophages, promoting their ability to ingest and destroy microbes [122]. Thus, all of these 
elements together could build a positive feedback loop, increasing expression of T-bet as well as 
early pro-inflammatory responses. Consistent with our results, Charles and colleagues previously 
reported that patients undergoing colonic resection showed a significant increase of Th1 
cytokines three hours past surgery [123]. 
Sean et al. showed that the concentration of Th1 specific cytokine IFN-γ in peripheral blood 
samples was suppressed in burn and trauma patients[124]. Wu and colleagues demonstrated that 
the percentage of Th cells decreased significantly on the first postoperative day when compared 
to preoperative values, but returned to preoperative levels on the second postoperative day [125]. 
In our study, we observed a similar phenomenon. T-bet expression dropped on the first 
postoperative day and was slightly lower compared to its preoperative level. This lower level 
continued for the next two days.  
Although no statistical difference was found for pre- and postoperative T-bet levels, a decrease 
of T-bet on postoperative day one and relatively low T-bet levels during the following 
postoperative days imply that T-bet was down-regulated and that Th1 function might have been 
impaired, too. Observational studies after major surgery showed that after operative trauma in 
the early postoperative phase anti-inflammation or even immune-suppression can prevail [126, 
127]. As far as we know no randomized controlled trials have been performed to investigate this 
central issue in a lung-surgery setting, so that it remains difficult to compare our results with 
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other studies. Of course, because of our study design, we have no evidence to support our 
hypotheses. The central limitation-factor of this study is the absence of assessment of cytokine 
signalling. On the other hand, none of our patients showed SIRS or other inflammation or 
infection symptoms. We assume that no greater, clinically relevant immune-impairment took 
place and speculate that the cytokine signalling described in other studies took place in our 
patients too. 
 
4.2 GATA3 expression 
In the present study, GATA3 expression showed fluctuations with small range tendencies: a 
slight increase during the operation and a decrease below preoperative levels after the operation, 
however not of statistical significance. 
Following hepatobiliary pancreatic surgery, GATA 3 mRNA expression level was slightly 
increased before surgery and further increased on postoperative day 3, 7, and 14 in patients with 
postoperative infection (P < 0.05) [116]. 
Therefore, the controlled GATA 3 response in our study might show a better maintained immune 
reactivity, this is clinically coincident because no obvious infectious signs were seen 
postoperatively. 
Generally it is thought that trauma produces a shift towards a Th2 response, the degree of which 
is proportional to the magnitude of trauma involved [128]. Decker et al revealed that Th subsets 
of patients after conventional aortic aneurysm repair showed a significant shift towards Th2 
immunity, which was expressed by the ratio of IFN-γ/IL-4 producing T cells, as well as by the 
ratio of HLA-DR+ monocytes/CD23+ B-cells) [129]. Hensler and co workers also showed that 
during the postoperative period after major elective surgery, cytokine levels were decreased for 
IL-2 and IFN-γ, which are associated with Th1 immunity. In contrast to this, anti-inflammatory 
cytokine IL-10 was selectively elevated during the late postoperative period, indicating a shift of 
the Th1/Th2 balance towards a Th2 response [92].In our study,GATA3 expression after surgery 
showed only non-significant trends compared to preoperative base line. The role of Th2 
immunity and its specific transcription factor GATA3 in perioperative immune responses needs 
further study. And, again, the central limitation-factor of this study is the absence of assessment 
of cytokine signalling. No specific literature showing the perioperative expression of GATA3 in 
a similar setting has been performed, thus making a comparison with other results merely 





4.3 FOXP3 expression 
In the present study, the level of FOXP3 decreased slightly since the beginning of the operation, 
and kept this relative low level until the end of the investigation period. However, the extent of 
alterations was not significant as compared with the time point prod.  
 
There is not any study on this T cell transcription factor in surgical settings yet. 
 
There is some evidence that suggests a correlation between the expression level of FOXP3 and 
the activity of Treg. Previous in vitro experiments revealed that Treg has the ability to suppress 
the proliferation of Th cells primarily in a contact-dependent manner [130]. In animal 
experiments, Treg was revealed to suppress Th1 immune responses and promote a shift towards 
Th2 immunosuppressive responses in mice after burn injury [131]. More recently, Mac Conmara 
and colleagues observed an alteration of Treg in humans after serious injury, as well as of Th1 
immunity. They showed for the first time that Treg was significantly increased in trauma patients 
which showed a suppressed Th1 immunity [132]. But this phenomenon was not found in our 
study. One possible reason is that the magnitude of injury in our study is not as hard as in theirs. 
Another possible explanation is the different follow up: 3 days in our study and 7 days after 
trauma. According to the short history of Treg and FOXP3, findings of Mac Conmara’s and our 
study still not assess enough evidence to explain the role of Treg and FOXP3 in human immune 
responses after injury. Further studies including the assessment of cytokines signalling are 
needed to address this issue. 
 
4.4 ROR-γ expression 
Recently Pene and his group found out that chronically inflamed human tissues are being 
infiltrated by highly differentiated Th17 cells. IL-17 and IL-22 concentrations secreted by tissue 
infiltrating Th17 cells also reached high levels while Th1/Th2 associated cytokines were 
correlatively depressed [133]. In contrast to these findings, ROR-γ levels in our study showed 
only slight and transient increases during the operation and a return to preoperative levels during 
postoperative days. No statistical significances could have been found.  




No perioperative studies investigating ROR-γ have been performed yet. 
 
An apparent difference between the studies above and ours is that the studies above both tested 
samples from local inflammatory sites, while we measured systemic levels of ROR-γ. This 
implies that Th17 may exert its major role locally in injured tissues. Consistent with our study, 
Frangen and colleagues retrospectively analyzed systemic concentrations of IL-17 and IL-6 of 71 
patients diagnosed with polytrauma and described that only 6% of patients showed significant 
elevations of IL17 [134]. Their study disagrees with systemic IL 17 as marker of immune 
response, too. So far, the exact function of this new T cell subset and its specific transcription 
factor ROR-γ remains unexplained considering human immune responses and particularly acute 
inflammation and needs to be investigated in larger controlled trials with regard to IL-17 
cytokine signalling. 
 
4.5 SOCS1 expression 
In our study, SOCS1 levels fluctuated during surgery and declined during the postoperative 
period. It is known that the SOCS1 promoter contains STAT1-, STAT3- and STAT6- binding 
sites. If surgical induced immune mediators have the ability to bind with these sites, they would 
synchronously initiate the expression of SOCS1 [135]. Surgical trauma normally causes the 
release of various cytokines and induces differentiation of T cell subsets. IFN-γ activates JAK1, 
JAK2 and induces STAT1; IL-6 mainly activates STAT3 through JAK1. Th1 development is 
controlled by IL-12-dependent STAT4 and Th2 is so by IL-4-dependent STAT6 activation. 
Recently, several studies proved that SOCS proteins are involved in the negative modulation of 
the JAK-STAT pathway, playing an essential role for proper homeostasis of immune responses 
[135, 136]. An activation of the JAK-STAT pathway in an immune response may induce 
transcription of SOCS, which then inhibits the JAK-STAT pathway. Although our findings were 
not of statistical relevance and did not include the assessment of cytokine signalling, they might 
show a trend describing SOCS1 activation during surgery. 
 
4.6 SOCS3 expression 
An increase of SOCS3 in the perioperative period was observed in our study. Between beginning 
and end of surgery, levels of SOCS3 mRNA significantly rose to a maximum of up to 13-fold. 
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Like SOCS1, SOCS3 is also regulated by STATs and its promoter contains STAT1 and STAT3 
binding sites. Studies targeting cytokine signalling demonstrated that IL-6 induced an activation 
of STAT1 and STAT3, while IL-10 induced the an activation of STAT3 [137, 138]. An increase 
of inflammatory cytokines like IL-6 and IL-10 is frequently seen after surgery or trauma. An 
elevation of IL-6 was reported in patients after major orthopaedic surgery [139]. In addition, both 
IL-6 and IL-10 were described to be significantly increased in patients with cancer after major 
surgery [137]. Therefore, we speculate that the release of IL-6 and IL-10 after surgical injury 
would be expected to activate transcription of SOCS3 as shown in our study. However no 
cytokine signalling assessment was performed in this study. 
 
4.7 Correlation between T-bet and SOCS1 
In our study, T-bet expression significantly increased during surgery. T-bet is the specific 
transcription factor of Th1 immunity. IFN-γ is the major effector cytokine of Th1 and its 
expression is linked to T-bet expression as shown in animal experiments with knock out mice 
[12]. In addition, these experiments with knockout mice indicate that IFN-γ is able to induce 
SOCS1 expression via STAT1and that SOCS1 is indispensable for the negative regulation of 
IFN-γ [140]. Mice with knocked out SOCS1 showed stunted growth and finally died within three 
weeks of age of a syndrome characterized by severe lymphopenia, activation of peripheral T 
cells, fatty liver degeneration and necrosis as well as macrophage infiltration of major organs, 
primarily attributed to unbridled IFN-γ signalling [140, 141]. Therefore we suppose that the 
increment of SOCS1 during surgery might be, at least partially, correspondent to the activation 
of T-bet, in order to negatively regulate Th1 cell differentiation, preventing a formation of 
activated Th1 cells producing excess IFN-γ. 
While IFN-γ is not the only cytokine that is able to induce SOCS1, other immune mediators, like 
IL-6, TNF, IL-12 have also been demonstrated to have this capability[142-144]. In order to 
confirm that this change of SOCS1 is mainly corresponding to that of T-bet, we further analyzed 
their correlation. We found that levels of SOCS1 had a significant correlation with levels of T-
bet on most time points, except for the time point of first postoperative, which only showed a 
trend (Table 18). Although we did not assess the cytokine signalling in our patients, these results 
could be supported by findings from Charles E. Egwuagu and colleagues. They reported that 
differentiation of naïve Th cells into Th1 or Th2 phenotypes is accompanied by preferential 
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expression of distinct SOCS proteins and that SOCS1 expression is 5-fold higher in Th1 than in 
Th2 cells [70]. Our study demonstrates that SOCS1 transcription levels are increased by lung 
surgery and significantly correlate to an activation of T-bet.  
 
4.8 Correlation between GATA3 and SOCS3 
IL-6 and IL-10 are both key cytokines of the Th2 answer. Therefore, we further analyzed the 
relationship between GATA3 and SOCS3, to find out whether the change of SOCS3 is mainly 
due to an activation of GATA3, marker of Th2 differentiation. However, analysis showed that 
SOCS3 did not correlate with GATA3 at any time point (Table 19). The reason for this 
unexpected result may be that IL6 and IL10 are also secreted from other immune cells, such as 
macrophages or dendritic cells. Furthermore, Th2 cytokines, including IL-6 and IL-10, are not 
the only cytokines induced by SOCS3 [145]. Besides, SOCS3 is not exclusively induced by 
STAT1 and STAT3. The slight trend ofGATA3 expression does not support this hypothesis 
either. In other words, while transcription of SOCS3 mRNA is extremely activated during lung 
surgery, GATA3 is probably not the main trigger of this SOCS3 activation. Further larger studies 
including cytokine signalling are needed to clear this question  
 
4.9 Epidural versus intravenous analgesia: 
Pain, anaesthesia and surgical trauma are major stress factors causing immunological alterations 
in perioperative settings. Different pain management concepts may affect immune responses in 
different ways. Supporting this idea, in patients receiving epidural anaesthesia, Holte and Kehlet 
demonstrated a reduction of fat metabolism, lactate and ketones, as well as reduced 
concentrations of endocrine and metabolic response parameters such as catecholamines, cortisol 
and glucose [146]. Hole also reported that lymphocyte and monocyte function was suppressed 
during general anaesthesia but maintained during epidural anaesthesia in patients undergoing 
total hip replacement [147, 148].  
Many studies suggest that epidural/spinal anaesthesia has a better protective effect against 
perioperative stress. A meta-analysis concluded that epidural anaesthesia decreased the overall 
mortality by approximately one-third, reduced the odds of deep vein thrombosis by 44%, 
pulmonary embolism by 55%, transfusion requirements by 50%, pneumonia by 39% and 
respiratory depression by 59%. Incidences of myocardial infarction and renal failure were also 
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reduced [149]. This advantage might be explained by the mechanism of epidural anaesthesia. 
Confronted with surgical stress, epidural nerve blocks not only provide analgesia but also 
decrease neuroendocrine stress by blocking both ascending sensory pathways and descending 
sympathetic efferences. It is also well accepted that immune system and nervous systems 
mutually communicate and influence each other [150, 151]. 
In this study, we observed the mRNA expression of main known Th cell transcription factors in 
patients intraoperatively receiving either remifentanil intravenously or ropivacaine epidurally as 
analgesia. Our results showed that mRNA alterations of all tested transcription factors are 
completely comparable for both groups receiving lung surgery for every sampling time point 
with the exception of T-bet. T-bet expression showed a significant increment after surgery in the 
remifentanil group alone, while the ropivacaine group showed no significant increase after 
surgery but depicts a trend towards the same direction. Referring to immune function, we did not 
find any advantages of epidural analgesia over intravenous analgesia. Similar to our study, 
Kawasaki and his group investigated effects of different anaesthesia methods on surgical induced 
immune responses in patients undergoing upper abdominal surgery. They did not find any 
advantages from epidural anaesthesia over general anaesthesia [114]. A similarity between the 
present study and Kawasaki’s is that the regions operated on include regions innervated by the 
phrenic nerve. It is easy to accept that a complete blockade of the afferent pathway should 
include the phrenic nerve. However, a complete block of the phrenic nerve can only be achieved 
by an epidural block as high as C3-C4, this cannot be achieved by thoracic epidural 
catheterisation. So, an incomplete block of the phrenic nerve in the operating field might mask 
benefits of epidural analgesia affecting immune function. Another possible bias may also lie in 
the large quantities of cytokines released in the region operated on, which might directly activate 
stress responses. Taken together, epidural analgesia did not show different effects on Th cell 
transcription factors in thoracic surgery as intravenous analgesia. 
Propofol was applied for anaesthesia induction and maintenance in both groups. Some groups 
investigated its effects on T helper cells and immune function. Pirttikangas et al. investigated 
changes of T cells in patients after minor breast surgery and found that propofol can cause an 
increase of Th cell percentage compared to thiopental [152]. This made us consider that besides 
surgical stress, Propofol could have been another trigger for T-bet and GATA3 stimulation during 
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surgery. However, results from the M. Salo groups, who studied effects of Propofol infusion on 
Th1/Th2 balance by measurements of IFN-γ and IL-4 production in vitro revealed that Propofol 
at serum concentrations of 3.5μg/ml did not affect the IFN-γ/IL-4 ratio [153]. This dosage is 
higher than the blood concentration in general anaesthesia, which normally measures about 2.5 
µg/ml [154]. In addition, Propofol was previously proved to inhibit the production of cortisol in 
a dose-related manner in vitro [155]. This profile implied that Propofol might impact immune 
function through the endocrine system. But van Hemelrijck et al. demonstrated that clinical 
doses of propofol (90-200 µg/kg/min) did not affect cortisol synthesis or the response to 
adrenocorticotropic hormone (ACTH) stimulation in vivo[156]. Therefore, the infusion of 
Propofol seems to be unlikely to affect the immune function in the perioperative setting. 
 
4.10 Limitations 
The major limitations of the present study were: 
1) The cytokine signalling downstream of the transcription factors has not been measured. The 
perioperative reaction on protein level described in the current literature has not been verified 
and our conclusions must remain speculative. 
2) The mRNA expression of transcription factors in whole blood provides only a surrogate 
parameter for evaluating the dynamic of immune responses in very complex pathways.  
3) The number of patients randomised in the two groups was small; therefore, the risk of a type 2 
error cannot be excluded. 
4) All patients were treated with thoracic epidural block after surgery in order to provide our 
patients with state of the art analgesia. The study specific treatment was limited to the 
intraoperative period. 
However, biases were kept as much reduced as possible: 
• Study design: In order to minimise biases we planned a prospective, randomised, 
double-blind, controlled trial. The project was approved by the local ethics committee 
and the German Federal Institute for Drugs and Medical Devices (BfArM). 
• Patient selection and exclusion criteria: Consecutive patients were screened and 
exclusion criteria were predefined in the study protocol. Particularly, no patients with 
pre-existing imbalances of the immune system were included into the study in order 
to minimise biases. 
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• Clinical settings: All patients were operated in the same centre by the same team 
following a predefined protocol in order to allow comparable general conditions for 
each patient. Blood withdrawals were performed on predefined time points following 
a standardised protocol. 
• Laboratory techniques: The PAXgene blood RNA system used in this study provides 
an efficient and standardized method for blood collection. This product reduces RNA 
degradation and prevents it from any post-sampling stimulation, which is essential for 
the investigation of highly reactive genes. Indeed, some previously published studies 
showed that blood collection in EDTA tubes and cell purification is accompanied by 
profound changes in mRNA expression [157]. Despite several sources of data 
variation, Bustin et al. suggested that fluorescence based qRT-PCR provides more 
sensitivity and specificity to the detection of mRNA levels as compared with 
conventional PCR [158, 159]. The qRT-PCR uses fluorescent reporter dyes to 
combine amplification and detection steps ofthe PCR reaction in a single tube format. 
The assay relies on measuring an increase in fluorescent signal, which is proportional 
to the amount of DNA produced during each PCR cycle. The use of TaqMan in the 
present study is also essential for its accuracy. The main advantage of qRT-PCR with 
TaqMan chemistry is its selective detection of accumulating specific setting PCR 
products and the fact that is does not bind all double-stranded DNA which includes 
non-specific reaction products. To minimize the bias of mRNA level differences 
between patients, a 2-ΔΛCT method was used for calculation and analysis of qRT-PCR 
data.  
• Demographics and clinical characteristics: Demographic and clinical characteristics 
such as age, sex, BMI, ASA-classification, cardiovascular diseases, beta-blocker 
therapy, anti-diabetic therapy and current Smoking did not differ between both groups. 
In addition, anaesthesia time, surgery duration and techniques did not show any 
significant differences between the two groups. These are favourable premises for a 
reliable comparison between groups. 
4.11 Conclusions 
1) T-bet expression was significantly increased after surgery compared to base line. Subgroup 
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analysis showed that T-bet expression was significantly increased in the remifentanil group but 
not in the ropivacaine group, which only showed a trend towards the same direction. 
2) SOCS3 expression showed no difference between groups. The n-fold changes of T-bet 
significantly correlate with the n-fold changes of SOCS1 at all time points except for the first 
postoperative day, which nevertheless shows a clear trend. 
3) This study showed that maintaining intraoperative analgesia with ropivacaine via thoracic 
epidural catheter or remifentanil i.v. did not show significant differences in the transcription 
factors despite the fact that T-bet differed between groups immediately after surgery. Due to the 
fact that clinical outcome did not differ between groups, it can be assumed that the intraoperative 
analgesia considering the minimal effects on the transcriptional level can be maintained with any 
of these procedures. The postoperative period was not investigated as it was considered not to be 
ethical to allow that patients might suffer from more pain than unavoidable because they are 
denied to benefit from the evidence-based better maintained analgesia with the epidural catheter 
after surgery. 
 




Lung surgery causes serious alterations of human immune functions, the extent of which 
subsequently impacts patients’ outcome. T cells, including subtypes Th1, Th2, Treg and Th17, 
play an important role in the immune response, involving both cell mediated and humoral 
immunity. There is some evidence that the differentiation and development of these Th cell 
subsets are controlled by their specific transcription factors T-bet, GATA3, FOXP3 and ROR-γ, 
and that they are being negatively regulated by SOCS1 and SOCS3. Different pain management 
may lead to different perioperative inflammatory reactions. In this study we investigated the 
perioperative alterations of these transcription factors, aiming to achieve a deeper understanding 
of the differences in the perioperative immune response at the genetic level between thoracic 
epidural block compared to i.v. analgesia. 
After having obtained written informed consent, 40 patients were allocated randomly and 
received either intravenous remifentanil analgesia or epidural ropivacaine analgesia in a 
doubleblind manner. Blood samples were collected on the day before the operation as baseline, 
the point of lung resection, the end of operation and the first, second and third postoperative day. 
Total blood mRNA was extracted and synthesized into cDNA. Relative mRNA expression of the 
genes T-bet, FOXP3, ROR-γ, SOCS1 and SOCS3 was measured by quantitative real time PCR. 
Relative alterations compared to baseline levels were calculated using the 2-ΔΛCT method. 
Surgical stress rapidly induced the increase of T-bet and SOCS3 in the remifentanil group in a 
significant way whereas this wasn’t the case in the ropivacaine group. Further significant 
changes were not to be found. Alterations of SOCS1 and T-bet expression levels were 
significantly correlated over the perioperative period. No difference between the two groups in 
basic patient characteristics and clinical outcome were seen. 
The significant immediate postoperative elevation of the transcription factors T-bet and SOCS3 
in the remifentanil group might be a hint for an accentuated inflammation due to operative stress. 
Nevertheless one has to take into account the fact that downstream cytokine signalling was not 
investigated, which is a major drawback of this thesis. A significant difference between the 
groups in the clinical course could not be found. However it has to be considered that for ethical 
reasons postoperative analgesia was maintained using the epidural catheter in both groups. 




Operative Eingriffe an der Lunge verursachen tief greifende, outcome-relevante Veränderungen 
des Immunsystems. T-Lymphozyten und deren Subpopulationen Th1, Th2, Treg und Th17 
spielen eine Schlüsselrolle sowohl in der zellulären als auch in der humoralen Immunabwehr. Es 
gibt Hinweise darauf, dass die Differenzierung und Entwicklung dieser Subpopulationen durch 
die für sie spezifischen Transkriptionsfaktoren T-bet, GATA3, FOXP3 und ROR-γ gesteuert und 
durch die inhibitorischen Faktoren SOCS1 und SOCS3 gehemmt werden. Verschiedene 
Schmerztherapiekonzepte können zu unterschiedlichen perioperativen Inflammationsreaktionen 
führen. In dieser Studie wurden die entsprechenden Veränderungen dieser Transkriptionsfaktoren 
untersucht, um ein tieferes Verständnis der Unterschiede zwischen thorakaler Periduralanalgesie 
und intravenöser Opiatanalgesie in Bezug auf die perioperative Immunreaktion auf der 
genetischen Ebene zu gewinnen. 
Vierzig Patienten wurden nach Aufklärung und Einwilligung in zwei Gruppen randomisiert und 
erhielten doppelblind entweder eine thorakale Periduralanalgesie oder eine kontinuierliche 
intravenöse Opiatanalgesie mit Remifentanil. Die Blutentnahmen erfolgten präoperativ als 
Baseline, intraoperativ zum Zeitpunkt der Lungenresektion, am Ende der Operation und jeweils 
am ersten, zweiten und dritten postoperativen Tag. Aus den Blutproben wurde mRNA extrahiert 
und in cDNA umgeschrieben. Mittels quantitativer RT-PCR wurde die relative Genexpression 
der Transkriptionsfaktoren T-bet, FOXP3, ROR-γ, SOCS1 and SOCS3 gemessen. Relative 
Veränderungen der Genexpression in Bezug auf die Baseline wurden mit der 2-ΔΛCT-Methode 
ermittelt. 
Infolge des durch die Lungenresektion verursachten operativen Stresses stiegen die 
Transkriptionsfaktoren T-bet und SOCS3 in der Remifentanilgruppe unmittelbar postoperativ im 
Vergleich zur Ropivacaingruppe signifikant an. Weitere signifikante Veränderungen konnten 
nicht gefunden werden. Veränderungen der Genexpression des inhibierenden Faktors SOCS1 
und des Th1-spezifischen Faktors T-bet zeigten eine signifikante Korrelation über die gesamte 
perioperative Zeit. Es haben sich zwischen den Gruppen keine Unterschiede in den 
demografischen und klinischen Merkmalen der Patienten sowie im klinischen Outcome gezeigt. 
Die unmittelbar postoperativ signifikant erhöhten Transkriptionsfaktoren T-bet und SOCS3 in 
der Remifentanilgruppe könnten ein Hinweis darauf sein, dass der operative Stress zu einer 
stärkeren Inflammation geführt hat, obwohl in Betracht gezogen werden muss, dass die 
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Zytokinexpression am Ende der Kaskade nicht erfasst wurde, was die Haupteinschränkung 
dieser Studie bezüglich ihrer Aussagekraft darstellt. Klinisch konnte kein signifikanter 
Unterschied zwischen beiden Gruppen gefunden werden. Dennoch sollte beachtet werden, dass 
beide Gruppen aus ethischen Gründen eine postoperative Analgesie mit Ropivacain epidural 
erhielten. 
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List of Abbreviations 
 
ACTH AdrenoCorticoTropic Hormone 
APC Antigen Presenting Cell 
ASA American Society of Anesthesiologist score 
BMI Body Mass Index 
BS Blood Samples 
CABG Coronary Artery Bypass Grafting 
CD Cluster of Differentiation 
CDC Centers for Desease Control and prevention 
cDNA complementary DeoxyriboNucleic Acid 
Ch Charrier 
CI Clearance Index 
CIS Cytokine-Inducable SH2 protein 
CNS Central Nervous System 
CSF CerebroSpinal Fluid 
Ct threshold cycle 
ECG ElectroCardioGramm 
EDTA EthyleneDiamineTetraacetic Acid 
F French 
FiO2 inspiratory Oxygen concentration 
FOXP3 FOrkhead boX P3 
GATA able to bind to the sequence G-A-T-A 
H20 Water 
HLA-DR Human Leukocyte Antigen DR 
HPA Hypothalamic Pituitary Adrenal 
IBP continuous Invasive Blood Pressure 
HPRT Hypoxanthine PhosphoRibosylTransferase 1 
ICU Intensive Care Unit 
IFN Interferon 
IL Interleukin 
iop intraoperative (during lung resection) 
i.v. intravenous 
JAKs Janus kinases 
LIFR Leukaemia Inhibitory Factor Receptor 
LPS LipoPolySaccharides 
LTi Lymphoid Tissue inducer 
MHC II Major Histocompatibility Complex II 
MODS Multi Organ Dysfunction Syndrome 
mRNA messenger RiboNucleic Acid 
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NIBP Non-Invasive Blood Pressure 
NK cell Natural Killer cell 
NTC Non Template Control 
NYHA New York Heart Association functional classification 
OLV One Lung Ventilation 
OP OPeration 
opd operative day (on arrival at the intensive care unit) 
PEEP Positive End-Expiratory Pressure 
postopd postoperative day 
qRT-PCR quantitative real-time Reverse Transcription Polymerase Chain 
R iRR Respiration Rate 
SaO2 Oxygen Saturation 
SEM Standard Error of Mean 
SH2 domain Src (structurally conserved region) Homology 2 domain 
SIRS Systemic Inflammatory Response Syndrom 
SOCS Suppressor Of Cytokine Signalling 
STAT Signal Transducers and Activators of Transcription 
SV Single Volume 
T-bet T-box expressed in T cells 
Tc T Cytotoxic lymphocyte 
TCR T Cell Receptor 
TEA Thoracic Epidural Anaesthesia 
TEB Thoracic Epidural Block 
TGF Transforming Growth Factor 
Th  T helper lymphocyte 
TIVA Total IntraVenous Anaesthesia  
TLR Toll-Like Receptor 
TNF Tumor Necrosis Factor 
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